metoprolol has been researched along with Myeloproliferative Disorders in 1 studies
Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.
Myeloproliferative Disorders: Conditions which cause proliferation of hemopoietically active tissue or of tissue which has embryonic hemopoietic potential. They all involve dysregulation of multipotent MYELOID PROGENITOR CELLS, most often caused by a mutation in the JAK2 PROTEIN TYROSINE KINASE.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Therefore, 50 mg of metoprolol (a selective beta-I-receptor blocking agent) was given by mouth to three groups of subjects: (1) 15 healthy volunteers, (2) five asplenic subjects, and (3) 10 patients with different myeloproliferative disorders (MPD) with and without splenomegaly." | 3.65 | The exchangeable splenic platelet pool in response to selective adrenergic beta-i-receptor blockade. ( Fredén, K; Kutti, J; Lundborg, P; Melberg, PE, 1977) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kutti, J | 1 |
| Fredén, K | 1 |
| Melberg, PE | 1 |
| Lundborg, P | 1 |
1 other study available for metoprolol and Myeloproliferative Disorders
| Article | Year |
|---|---|
The exchangeable splenic platelet pool in response to selective adrenergic beta-i-receptor blockade.
Topics: Adolescent; Adult; Blood Cell Count; Blood Platelets; Female; Humans; Male; Metoprolol; Middle Aged; | 1977 |